Browsing Category
Lipids
The prominence of the dosage form design to treat ocular diseases
The eye is susceptible to various diseases commonly difficult to treat. To overcome the barriers imposed by this organ for required drugs penetration, technological strategies have been implemented to ocular formulations. Among them are the use of temperature or electric stimuli and the development…
Read More...
Read More...
Dermal Pharmacokinetics of rivastigmine-loaded liposomes: an Ex vivo- in vivo correlation study
The aim of the present study was to develop a topical liposomal formulation as a transdermal delivery of rivastigmine for the treatment of Alzheimer disease as an alternative to the oral dosage form and to achieve smooth continuous drug delivery and maintain plasma levels within the therapeutic…
Read More...
Read More...
Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells – but where is…
Peptides are therapeutic molecules with high potential to treat a wide variety of diseases. They are large hydrophilic compounds for which absorption is limited by the intestinal epithelial border covered by mucus. This study aimed to evaluate the potential of Hydrophobic Ion Pairing combined with…
Read More...
Read More...
Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of…
The aim of this study was to fabricate nanostructured lipid carriers, NLCs, of nintedanib (BIBF) to improve its oral bioavailability. Two types of NLCs loaded with BIBF (BIBF-NLCs-1 and BIBF-NLCs-2) were prepared by the melt-emulsification technique. BIBF-NLCs-1 and BIBF-NLCs-2 showed nanoscale…
Read More...
Read More...
Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve…
Bacterial endophthalmitis (BE) is a potentially sight-threatening inflammatory reaction of the intraocular fluids or tissues caused by bacteria. Ciprofloxacin (CIP) eye drops are prescribed as first-line therapy in BE. However, frequent administration is necessary due to precorneal loss and poor…
Read More...
Read More...
Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions
Highlights
Labeling by ACQ fluorophores enabled accurate bioimaging of nanoemulsions.
Nanoemulsions were cleared rapidly from the blood.
Nanoemulsions were mainly taken up by the liver after intravenous administration.
Particle size has significant influence on the…
Read More...
Read More...
Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting:…
Adefovir dipivoxil (AD), a nucleoside reverse transcriptase inhibitor is effective against Hepatitis B virus. Its poor oral bioavailability leads to frequent administration causing severe adverse effects. Thereby the entrapment of AD within lipid nanoparticulate systems is a way of increasing AD…
Read More...
Read More...
In Vitro Performance and Chemical Stability of Lipid-Based Formulations Encapsulated in a Mesoporous…
Lipid-based formulations can circumvent the low aqueous solubility of problematic drug compounds and increase their oral absorption. As these formulations are often physically unstable and costly to manufacture, solidification has been suggested as a way to minimize these issues. This study…
Read More...
Read More...
Guaranteeing excipient quality by Gattefossé
For Gattefossé, quality is a strategic driver for progress which is fully integrated in every process we undertake, from research to product delivery to our customers.
Our quality policies are constantly upgraded to meet and even exceed our customers’ expectations.
We are regularly audited by…
Read More...
Read More...
Phospholipid-Based Delivery Systems – Phospholipids as Excipients in Advanced Veterinary Drugs
Advanced Veterinary Drugs by Using Phospholipids as Excipients
Phospholipids have been widely used as excipients in human medicine for decades. In veterinary medicine, too, there are various products on the market, which take advantage of the versatile benefits of phospholipids. These natural,…
Read More...
Read More...